The spleen tyrosine kinase family members Syk and Zap-70 are pivotal signal transducers downstream of antigen receptors and exhibit overlapping expression patterns at early lymphocytic developmental stages. To assess their differential kinase fitness in vivo, we generated mice, which carry a Zap-70 cDNA knock-in controlled by intrinsic Syk promoter elements that disrupts wild-type Syk expression. Kinase replacement severely compromised Erk1/2-mediated survival and proper selection of developing B cells at central and peripheral checkpoints, demonstrating critical dependence on BCR signalling quality. Furthermore, ITAM-and hemITAM-mediated activation of platelets and neutrophils was completely blunted, while surprisingly FccR-mediated phagocytosis in macrophages was retained. The alteration in BCR signalling quality resulted in preferential development and survival of marginal zone B cells and prominent autoreactivity, causing the generation of anti-insulin antibodies and agerelated glomerulonephritis. Development of concomitant fasting glucose intolerance in knock-in mice highlights aberrant B cell selection as a potential risk factor for type 1 diabetes, and suggests altered BCR signalling as a mechanism to cause biased cellular and Ig repertoire selection, ultimately contributing to B cell-mediated autoimmune predisposition.
Introduction
The early presence of autoantibodies in numerous autoimmune diseases like multiple sclerosis (Obermeier et al, 2008) , systemic lupus erythematosus (Satoh et al, 2007) and type 1 diabetes (Bingley, 2010) , as well as the success of B cell ablation strategies in alleviating autoimmune disease (Hu et al, 2007; Zekavat et al, 2008) put B cells at centre stage as participants in the onset of pathology. Both, B cell autoantibody production and autoantigen presentation could contribute to the detrimental priming of potentially selfreactive T cells, but the mechanisms of B cell miss-priming still await full clarification. Signal transduction through the B cell receptor (BCR) determines proper B lymphocyte development, selection and reactivity via discrete signalling thresholds. Hence, during the last years attention has been drawn to critical signalling components downstream of the BCR and their contribution to proper B cell selection. Signal mediators like, for example, the Src kinase family member Lyn acting through CD22 and SHP-1 (Somani et al, 2001; Hibbs et al, 2002; Ferry et al, 2005; Dubois et al, 2006) , the Tec family kinase Btk (Middendorp et al, 2002; Kersseboom et al, 2006) and the negative regulatory protein tyrosine phosphatase Lyp (PTPN22) (Menard et al, 2011) have been associated with autoimmune phenotypes when either aberrantly expressed or mutated. As spleen tyrosine kinase family members have a central role in signal initiation downstream of antigen receptors, they might in terms of signalling quality serve as interesting candidates in the development of autoreactive B cells.
Whereas Zap-70, which is largely confined to T cells and NK cells (Chan et al, 1991) , translates TCR-and integrinmediated cues to the cell interior, Syk function predominates downstream of the BCR (DeFranco, 1987; Taniguchi et al, 1991) , Fc receptors (Agarwal et al, 1993; Kolanus et al, 1993; Kiefer et al, 1998) and C-type lectins like, for example, Dectin-1 (Osorio and Reis e Sousa, 2011) and CLEC-2 (Kerrigan and Brown, 2010) in numerous haematopoietic cells. Interestingly, Zap-70 expression was recently reported to parallel, although at low amounts, Syk expression in developing murine bone marrow B cells (Fallah-Arani et al, 2008) , and its presence is an essential prognostic marker for malignancy scoring of human B cell chronic lymphocytic leukaemia (Chen et al, 2002) . Inferred from the reported crystal structure of Zap-70 (Deindl et al, 2007) , Syk and Zap-70 likely adopt comparable autoinhibitory conformations and both kinases are allosterically activated through binding to phosphorylated ITAM (immunoreceptor tyrosine-based activation motif)-containing cytoplasmic receptor chains (Reth, 1989) . Lack of Syk in murine thymocytes causes a partial arrest at the pre-TCR b-chain selection stage of T cell development (Palacios and Weiss, 2007) , which suggests that differential kinase fitness was stringently adapted to the cellular and developmental contexts during B and T cell lymphocytic evolution. Syk is more readily activated by autophosphorylation compared to Zap-70, which appears to rely on Src-family kinases for full activation, leading to the notion that Syk is a more active kinase compared to Zap-70 (Rolli et al, 2002) . To assess general Syk-family kinase fitness in vivo in different cellular settings, we performed a kinase exchange expressing Zap-70 as a surrogate kinase of Syk. In particular, we wondered to which extent Zap-70 could functionally replace Syk.
In this study, we demonstrate that at comparable expression levels in vivo, Zap-70 acts as a hypoactive Syk surrogate downstream of ITAM-coupled immunoreceptors. Whereas the phagocytosis of B cell and Fcg receptors is unaffected by the kinase exchange, platelet, macrophage and neutrophil activation as well as concomitant induction of effector functions, like platelet degranulation and neutrophil reactive oxygen intermediate production, are significantly blunted through the Zap-70 knock-in. In B cells, where BCR signalling quality has a major influence on developmental processes, the kinase exchange results in a failure of proper B cell selection that predisposes to B cell-mediated autoimmunity and likely increases the risk for type 1 diabetes development.
Results

Generation of Syk Zap/Zap knock-in mice
The partly redundant expression pattern of Syk-family kinases made us question to which extent Syk and Zap-70 exhibit interchangeable functions when physiologically expressed under the control of intrinsic Syk promoter elements. Therefore, we inserted a human pA-tailed Zap-70 cDNA (NM_001079) into the first coding exon of Syk (Supplementary Figure 1A- Figure 1D) . Of note, knock-in mice on a mixed C57/BL6 Â129/Sv genetic background were vital and fertile, with normal lifespan up to the time points where animals were sacrificed for experiments (p60 weeks). This allowed the analysis of differential kinase and concomitant cellular fitness of various compartments and at any age of interest. In addition, heterozygous (Cheng et al, 1995; Turner et al, 1995; Schweighoffer et al, 2003) . Therefore, we analysed the capacity of Zap-70 to drive B cell development in our Syk Zap-70/Zap-70 knock-in mice (abbreviated Syk ki or ki (figures)) by multicolour flow cytometry following the Hardy classification scheme (Hardy et al, 1991) . Syk ki mice exhibited a significant reduction of fractions D-F (small pre-, immature, transitional B) compared to Syk þ / þ and Syk þ /Zap-70 mice ( Figure 1A ), which strongly affected total bone marrow cellularity, but left the myeloid (Gr1 þ ) compartment unaffected ( Figure 1D , Supplementary Figure 2A) . Essentially, B cell development partially arrested at the pre-BCR checkpoint ( Figure 1B and E, fraction C) where pairing and surface expression of successfully rearranged IgH chains with a germline-encoded surrogate light chain (VpreB and l5) triggers clonal pre-B cell expansion (Karasuyama et al, 1990) . The differentiation block was not caused by aberrant pre-BCR surface expression as l5 levels were comparable between Syk ctrl and Syk ki B220 þ CD43 þ B cells ( Figure 1F ).
In contrast to normal pre-BCR expression, forward scatter analysis of fraction A-C cells revealed a severe defect in pre-B blast formation ( Figure 1G , right). This was further corroborated by cell cycle analysis, which showed that Zap-70 is largely inferior to Syk in driving pre-B cells into S/G2/M phase ( Figure 1H and Supplementary Figure 2B ). Recent work by Yasuda et al (2008) indicated that cell cycle entry of pre-B cells requires the activation of Erk1/2 through the pre-BCR. We therefore stimulated Syk ki bone marrow B cells, consisting predominantly (B85%) of early (fraction A-C) B cell stages, with anti-CD79b (Igb) to mimic pre-BCR engagement and analysed pErk1/2 levels. Activation of Erk1/2 following CD79b ligation was severely compromised in Syk ki mice ( Figure 1I ), in which only strongly reduced numbers of cells successfully traversed to the small pre-B cell stage ( Figure 1C and E, fraction D). The reduced efficacy of passing the pre-BCR checkpoint was accompanied by an increase of early (AnnexinV þ PI À ) and late (AnnexinV Figure 2C) , which also includes apoptotic pre-B cells. Apoptosis rates of IgM þ (immature/transitional) Syk ki B cells were significantly elevated, which is likely explained by diminished prosurvival tonic BCR signalling (Supplementary Figure 2D) . Apart from the pre-BCR/BCR signalling defects in Syk ki mice, the developmental phenotype raised the question whether altered signalling quality through Zap-70 could potentially lead to an aberrant selection of a B cell pool prone to self reactivity.
Syk ki mice exhibit an age-related accumulation of marginal zone B cells
Although the number of Syk ki B cells successfully passing central development and populating the secondary lymphoid organs was significantly reduced (as exemplified by splenic B220 þ B cell counts, see Figure 2B ), notably,
to a lesser extent IgM lo/ À IgD þ mature B cells ( Figure 2B ).
Despite the diminished B cell compartment, total splenocyte numbers (Supplementary Figure 3A) were largely replenished by an accumulation of CD3 þ CD4 þ and CD3 þ CD8 þ T cells in the splenic white pulp ( Figure 2C ). In 8-to 10-week-old mice, despite their absolute and equal increase, neither
þ Syk ki T cells showed signs of pre-activation as measured by CD69 expression (Supplementary Figure 3B ). Also, the ratio of
hi (naive) Syk ki T cells was comparable to Syk ctrl ratios (Supplementary Figure 3D) . Splenic CD3 þ CD4 þ effector/ memory T cell numbers of Syk ki mice were increased to a lesser extent than their CD3 þ CD8 þ CD44 hi CD62L lo counterparts ( Figure 2D ), and the increase was counterbalanced by Figure 4D and E), which however, did not affect single/double positive or total thymic T cell numbers (Supplementary Figure 4A-C) . Recent studies (Siggs et al, 2007; Hsu et al, 2009 ) demonstrated that changing signalling quality through the TCR by hypomorphic Zap-70 alters the ratio of peripheral effector/memory versus naive T cells, affects nTreg numbers and predisposes to T cell-mediated autoimmunity. Our replacement of Syk by Zap-70 in thymocytes, however, had only a minor effect on the T cell compartment and resulted in a splenic white pulp 'fill up' by T cells balanced in subset ratios.
In contrast to the scarcely affected T cell populations, analysis of the B cell compartment revealed a rather unexpected pathogenesis apart from the severe B lymphopenia. Strikingly, Syk ki mice accumulated B220 þ CD21 hi CD23
lo/ À marginal zone (MZ) B cells from the age of 14 weeks onwards ( Figure 2F and G), a phenomenon previously described for non-obese diabetic mice (Marino et al, 2008) . MZ B cells constitute a population of likely transitional 2-derived, sessile and self-resplenishing cells with rarely somatically mutated mIg, harbouring carbohydrate and self-/polyreactive specificities (Grey et al, 1982; Li et al, 2002) . Syk ki splenic B cells partially arrest at the T2 stage and seem to be preferentially selected towards the MZ fate ( Figure 2A ). This is indicated by the fact that Syk ki MZ cells show a less severe reduction in cell number than the B220 þ CD21 int CD23 þ follicular (FO)/T2 compartment which in ki mice is mainly composed of IgM high T2 precursors ( Figure 2F and G). Concomitantly, isotype-switched serum IgG titres were decreased while sIgM predominated in Syk ki mice ( Figure 2H ). Taken together, our findings support the notion that BCR signalling quality is largely decisive to prime either towards the MZ or the FO B cell fate (Pillai and Cariappa, 2009 ).
Reduced Zap-70 kinase auto-and transphosphorylation activity result in diminished BCR-induced net-tyrosine phosphorylation, signal duration and Ca 2 þ flux
The differential requirements of Syk and Zap-70 to become fully activated and their substrate specificity have been under intense scrutiny since the first descriptions of the kinases about two decades ago (Chan et al, 1991; Taniguchi et al, 1991) . A recent publication (Tsang et al, 2008 ) made use of a real-time fluorescence kinase assay to quantitatively characterize the molecular mechanisms of Syk and Zap-70 kinase activation in vitro. The kinetics of auto-and substrate phosphorylation were slower and the V max was lower for Zap-70 compared to Syk. This finding supports the prevailing notion that Zap-70-mediated signalling indispensably relies on upstream Src-family kinase activity, while Syk can significantly contribute to its own activation and hence is more readily activated. To verify these findings, we stably expressed HA-tagged versions of a kinase-dead mutant 
þ pre-B cells using five-colour flow cytometry; numbers indicate representative percentages of pre-B cells in S/G2/M phase. (I) Total p42/p44 (Erk1/2) and phospho-p42/p44 (pErk1/2) levels of bone marrow cells left untreated ( À ) or treated ( þ ) with anti-CD79b (Igb) for 2 min at 371C. *Po0.05, **Po0.01, ***Po0.001; n ¼ 8 (A-E, G) and three (F, H, I) per group; error bars indicate means ± s.e.m. arb.u., arbitrary units; co, isotype control; Ig, immunoglobulin; ns, not significant. Figure 3A , left). We selected clones of equally low protein expression to avoid kinase pre-activation due to overexpression and determined the associated spontaneous kinase activity after HA-mediated immunoprecipitation. In line with earlier reports (Latour et al, 1996; Rolli et al, 2002) , the mere presence of the allosteric activator Igb sufficed to significantly activate Syk, while Zap-70 was inferior in cis but particularly in trans phosphorylation ( Figure 3A , right). Anti-IgM-induced phosphorylation of Igb was clearly weaker in primary Syk ki splenic B cells as compared to Syk ctrl B cells ( Figure 3B ) and in addition ITAM phosphorylation may have partly originated from Src kinase activity. Of note, precipitating Igb from Syk ki B cells yielded an additional band increasing in intensity with anti-IgM stimulation. Potentially, an increase in stimulation-dependent avidity of improperly self-restricted Syk ki BCRs, co-precipitating under mild detergent conditions, resulted in autoantigen trapping. To assess the capacity of Zap-70 to transduce BCR-mediated signals, we stimulated sorted B220 þ CD19 þ splenic B cells with anti-IgM F(ab 0 )2 and analysed net-phosphorylation kinetics by western blotting ( Figure 3C ). To further exclude the possibility that sorted B220 þ CD19 þ ctrl B cells, which are largely composed of mature IgM lo IgD hi cells, would bias the comparison of ex vivo kinase activity, we additionally compared ctrl B220 þ CD21 hi CD24 hi T2/MZ fraction B cells to ki B cells arresting mainly at the T2/MZ stage. In contrast to ctrl B cells, the Zap-70 knock-in generated a diminished BCRinduced net-phosphorylation response, resulting in faster off-signal kinetics. When we addressed anti-IgM-induced Ca 2 þ responses, Syk ki BCRs only started to mobilize intracellular Ca 2 þ at high ligand concentrations, whereas the storeoperated calcium entry (SOCE) into knock-in B cells was comparable to Syk ctrl cells ( Figure 3D ), indicating that Syk kinase activity is indispensable for Ca 2 þ signal initiation but largely dispensable for SOCE response regulation. þ and CD8 þ (CD3 þ -pre-gated) T cell numbers in ctrl and ki mice. (D) Numbers of (CD3 þ -pre-gated) CD44 hi CD62L lo effector/memory CD4 þ and CD8 þ T cell subsets and (E) ratio of splenic CD4 Figure 5A) . Furthermore, the surface expression of major glycoproteins and integrins was largely unchanged in Syk ki platelets compared to controls (Supplementary Figure 5B) and Zap-70 expression was readily detected in Syk ki platelets (Supplementary Figure 5C ). This excluded a lack of kinase expression through decreased protein stability as a possible reason for observed differences in platelet activation. To delineate potential activation deficiencies, we stimulated isolated platelets with various agonists and assessed their activation by flow cytometry, measuring activated aIIbb3-integrin by the use of the JON/A-PE antibody (Bergmeier et al, 2002 ; Figure 4A ) and degranulation-dependent P-selectin exposure ( Figure 4B activation and P-selectin upregulation remarkably failed to exceed resting state levels upon CRP, rhodocytin and convulxin stimulation. As aIIbb3 is the main platelet integrin mediating adhesion, aggregation and spreading to the extracellular matrix upon vessel injury , we investigated the potential of Syk ki platelets to aggregate in response to GPCR (thrombin), GPVI (collagen, CRP) and CLEC-2 (rhodocytin) stimulation ( Figure 4C ). In line with the flow cytometric data, Syk ki platelets failed to aggregate upon ITAM/hemITAM-coupled receptor triggering. The delayed and weak residual aggregation of Syk ki platelets to collagen ( Figure 4C , graph2) likely originated from integrin a2b1-mediated platelet attachment to the matrix protein followed by weak outside-in activation through the adhesion receptor. In contrast, no such response was observed upon CRP stimulation, which solely acts through GPVI. This altogether demonstrates that Zap-70 kinase is insufficient to sustain signalling downstream of ITAM-and hem-ITAM-coupled receptors in platelets.
Zap-70 kinase function suffices to trigger BCR-and FccR-mediated endocytosis, but fails to replace Syk in effective ROS production upon immune complex-mediated stimulation in neutrophils The failure of FcgR-mediated platelet activation in Syk ki mice raised the question whether ITAM-coupled receptors retained any functionality in mononuclear phagocytes and granulocytes. We therefore derived macrophages from bone marrow cultures and assessed their ability to phagocytose either E. coli pHrodo particles ( Figure 5A ) or IgG-coated sheep red 
þ ki B cells; black arrows indicate the addition of anti-IgM at concentrations depicted above response curves; red arrows mark the addition of extracellular Ca 2 þ (1.5 mM) to measure the store-operated calcium entry after depleting ER stores with anti-IgM (10 mg/ml); ionomycin was used as a positive control. Each figure is representative for three independent experimental repeats; KD, kinase-dead. ctrl, control; Ig, immunoglobulin. Figure source data can be found with the Supplementary data. blood cells (SRBCs; Figure 5B ) to discriminate ITAMindependent scavenger receptor-from ITAM-dependent FcgR-mediated phagocytosis. Overall, Syk ctrl and Syk ki macrophages showed comparable uptake kinetics in response to either stimulus, albeit FcgR-mediated SRBC uptake in knock-in macrophages was slightly delayed for the first 5 min (Figure 5B , right; P ¼ 0.047). Likewise, anti-IgM-induced BCR uptake kinetics were comparable between Syk ctrl and Syk ki splenic B220 þ B cells (Supplementary Figure 3B) .
These findings altogether indicated that Zap-70 can compensate for Syk in ITAM-coupled receptor internalization. Next, we isolated Syk ki polymorphonuclear neutrophils and analysed their ability to produce reactive oxygen species (ROS) upon BSA-IgG-H 2 DCF immune-complex-mediated FcgR triggering. Neutrophil uptake of E. coli pHrodo particles ( Figure 5C ) as well as the production of ROS upon bacterial tripeptide (fMLP) and PMA stimulation ( Figure 5D , right) were indistinguishable between Syk ctrl and Syk ki mice, demonstrating that both responses were principally unaffected by the kinase exchange. However, upon immune complex (IC) addition, the generation of reactive oxygen intermediates was significantly reduced ( Figure 5D , left), demonstrating that also in polymorphonuclear neutrophils the hypoactive surrogate kinase Zap-70 fails to compensate for essential Syk signalling functions downstream of FcgRs.
Syk
ki mice suffer from autoantibody immune complex-mediated glomerulonephritis and exhibit signs of a pre-diabetic state On the basis of our observation that Zap-70 has a weaker, but still significant, ability to drive B cell development, we hypothesized that B cells with potentially autoreactive BCR specificities were likely to misinterpret, otherwise proapoptotic, bone marrow-derived BCR signals due to attenuated signal transduction. To test whether the antibodies produced by Syk ki mice were properly self-restricted, we incubated human epithelial (Hep-) 2 cells with Syk ctrl ( Figure 6C , iii and iv) revealed that IC deposition strongly affected glomerular architecture, indicated by an increase of basement membrane, glomerular mesangial hypercellularity, mesangial matrix accumulation and an overall increase in Bowman capsule size ( Figure 6D ). Syk ki mice at the age of 12 weeks also exhibited mild but significant proteinuria ( Figure 6E ). The extensive cytoplasmic Hep-2 cell staining of Syk ki sera made us curious about the antigens recognized by Syk ki autoantibodies. Therefore, we analysed Syk ki serum reactivity towards dsDNA and insulin, two model antigens that are wellestablished targets in B cell co-mediated autoimmune disease. Intriguingly, sIgM of Syk ki mice showed no significant increase in anti-dsDNA reactivity compared to Syk ctrl sera, which correlated well with the lack of anti-nuclear Hep-2 staining ( Figure 6F ). However, Syk ki sera highly reacted to Figure 4 Impaired ITAM and hemITAM-coupled receptor signal transduction in Syk ki platelets. After stimulation with the indicated agonists, platelet surface levels of activated aIIbb3-integrin (JON/A-binding, A) and P-selectin (B) were measured by flow cytometry. Whereas GPCRmediated signal transduction (ADP, U46619, thrombin) was comparable in ctrl and ki platelets, signalling via GPVI (CRP/convulxin) and CLEC-2 (rhodocytin) failed to activate aIIbb3 or elicit Syk ki platelet degranulation responses. (C) Platelet aggregometry revealed impaired aggregation of Syk ki platelets in response to collagen, CRP and rhodocytin; arrows denote the addition of the agonists and each response curve covers 10 min of signal acquisition; *Po0.05, **Po0.01, ***Po0.001. CRP, collagen-related peptide; ctrl, control; CVX, convulxin; ns, not significant; rhod, rhodocytin.
Altered BCR signalling quality elicits autoimmunity S Kö nigsberger et al recombinant insulin (Figure 6G ), which could reflect a failure during negative selection of Syk ki B cells towards soluble rather than particulate antigens. Following overnight starvation, already at the age of 14 weeks, Syk ki mice showed significantly increased levels of fasting blood glucose ( Figure 6H) , one of the early hallmarks in the onset of type 1 diabetes. Intraperitoneal injection of D-glucose, however, resulted in comparable kinetics of blood glucose reduction in Syk ctrl and Syk ki mice ( Figure 6I ), confirming the pre-diabetic state. We additionally determined serum C-peptide, C3, C4, creatinine and BUN levels of 14-week-old ctrl and ki mice (Supplementary Figure 6A- Figure 6F) argues at least in young mice against severe renal damage and systemic complement activation. B cell autoantibody production and possible cognate feedback function for diabetogenic T cells may be counteracted by defects in IC and FcgR receptor-mediated activation of Syk ki APCs, however, this compensatory mechanism may be lost with increasing age.
E). The absence of overt inflammatory indicators and pancreatic infiltration (Supplementary
To further quantitate insulin-reactive clones within the Syk ki B cell pool, we performed Elispot assays on sorted splenic B220 þ CD19 þ B cells, which yielded, in contrast to the non-reactive wild-type controls, IgM reactivities towards insulin at a frequency of roughly 0.08% ( Figure 6J , right). On a systemic level, bacterial antigens have been suggested to rather protect from type 1 diabetes due to a shift towards T H 2-mediated immunity (Sadelain et al, 1990; Lee et al, 2004 ). In our model system of aberrantly selected B cells, ex vivo stimulation with lipopolysaccharide increased the amount of anti-insulin autoantibody production, as indicated by IgM spot enlargement ( Figure 6J , left). This finding, together with the recently reported splenic MZ helper response of neutrophils following LPS-mediated priming of macrophages and sinusoidal endothelial cells (Puga et al, 2011) , provokes the question whether the unfavourable combination of danger signals and autoantigenic responses by self-reactive BCRs might foster the survival of autoreactive clones, resulting in an increased likelihood of antigenic presentation to T cells. Altered BCR signalling quality elicits autoimmunity S Kö nigsberger et al downstream of BCRs. This allowed B cells to preferentially survive in the pool of MZ B cells, caused significant serum autoreactivity due to aberrant cellular selection and hence, increased the risk for autoimmune disease.
During development, lymphocytes encounter a first major checkpoint, which probes for successful rearrangement and surface expression of the IgH or TCRb chain by testing signalling through the pre-BCR and pre-TCR. Through the analysis of single and compound knockout mice, it has become clear that Syk and Zap-70 fulfil partially redundant functions downstream of these pre-antigen receptors. In T cells, Syk and Zap-70 both efficiently transduce pre-TCR signals and can largely replace each other. In mice deficient for either kinase, DP thymocytes are formed normally, while in double-deficient mice DP thymocyte formation is blocked (Cheng et al, 1997) . Elegant competitive transplantation experiments revealed, however, that Syk specifically confers increased functional fitness during b-chain selection (Palacios and Weiss, 2007) , allowing efficient transition from the DN3 to the DN4 stage. In pro-B cells, Syk is already superior to low levels of Zap-70 in supporting the pre-BCR-dependent pro-to pre-B cell transition. Consequently, Syk-deficient B cells display a partial block at this stage (Cheng et al, 1995; Turner et al, 1995) . Double-deficient pro-B cells lacking Syk and Zap-70 are completely blocked at the pro-to pre-B cell transition (Schweighoffer et al, 2003) . Retroviral rescue of Syk (Schweighoffer et al, 2003) . It rather suggests that an increase in Zap-70 expression, when driven by the Syk promoter, allows sufficient pre-BCR signalling, adding to the evidence that suggests functional complementation at the pre-BCR level. Syk ki B cells, although prone to higher apoptosis rates likely due to diminished BCR-mediated pErk1/ 2 prosurvival signals, successfully populated secondary lymphoid organs and organized into small B cell FO areas adjacent to enlarged T cell zones (data not shown). The improved capacity of Syk ki over Syk À / À B cells to pass the pre-B cell checkpoint and to differentiate into mature B cells may primarily be a consequence of the largely elevated expression of Zap-70 under the Syk promotor, providing enhanced kinase activity. Enzymatically, Syk is the more active kinase and depends to a lesser degree on upstream activation by Src kinases compared to Zap-70 (Kolanus et al, 1993; Latour et al, 1996) . In line with these findings, Syk ki BCRs were inferior in their ability to elicit efficient phosphotyrosine and Ca 2 þ responses and Syk more efficiently phosphorylated ITAM motifs, which subsequently act as allosteric kinase activators. These properties may explain the reduced pro-to pre-B cell transition of Syk ki compared to Syk ctrl B cells.
Furthermore, the SH2 domains of Syk both form a complete phosphotyrosine binding pocket, making them independently functional. In contrast, the N-terminal SH2-domain of Zap-70 is only capable of phosphotyrosine binding after establishing extensive contact with the C-terminal SH2 (SH2-C) domain, as part of the phosphotyrosine binding pocket is structurally provided by the SH2-C domain. This structural constraint results in a high selectivity of Zap-70 for the TCR/CD3 complex, which likely provides a conformational basis for the complete absence of hemITAM-and many FcgR-mediated signalling processes in Syk ki myeloid cells. Interestingly, receptor-dependent endocytosis pathways were completely preserved, which had previously been demonstrated to critically depend on Syk expression. Our novel findings indicate that the intracellular targets causing phagocytic responses are qualitatively different from those responsible for, e.g., ROS generation and integrin inside-out activation and possible differences could involve reactivity to a short burst of kinase activity rather than sustained and localized signalling.
A number of recent studies has highlighted Syk in autoimmunity-related disease, as deletion of Syk in neutrophils protects from autoimmune serum transfer arthritis in mice (Elliott et al, 2011) , hyperreactive/overexpressed Syk contributes to T cell malfunction in systemic lupus erythematosus (Krishnan et al, 2008) and targeting of Syk in dendritic cells abrogates FcgR-mediated cross-priming of diabetogenic T cells in RIP-mOVA mice (Colonna et al, 2010) . The implication of ITAM-coupled immunoreceptor signalling in autoimmune diseases has provoked efforts to pharmaceutically intervene with aberrant protein function as exemplified by the development of the pharmacological inhibitors fostamatinib/R788 (Pine et al, 2007) and PRT062607 (Flight, 2011) for the treatment of rheumatoid arthritis. While these studies aimed to interfere with the detrimental elevation of Syk-mediated signalling associated with a sustained inflammatory response, we here analyse an in vivo condition representing decreased Syk-family kinase signalling to assess the importance of Syk in the generation of properly selected lymphocytic pools and to determine potential disease correlates.
Surprisingly, Syk ki mice were viable and as homozygotes fertile, which allowed us not only to access the cellular consequences of the kinase exchange in various cell types, but also to assess its biological consequences in the absence of confounding factors like lethal irradiation and bone marrow transplants. An interesting finding in our model was that Syk ki B cells were preferentially selected and more readily survived within the pool of splenic MZ B cells. Earlier publications reported that after substantial reduction of autoreactive potential during positive (Keenan et al, 2008) and essentially negative (Wardemann et al, 2003) central selection, the IgM þ IgD þ T2 stage checkpoint of peripheral B cell development is decisive for FO versus MZ fate decision (Pillai and Cariappa, 2009 ). An alternative reason for the preferential selection/survival of MZ B cells in our model could be a preferential MZ fill up caused by lymphopenia, a phenomenon described for several BCR transgenic lines. In general, MZ B cells were reported to harbour autoreactive specificities and as they are potent activators of T cells due to a pre-activated phenotype must be properly excluded from follicles (Ekland et al, 2004) . On the basis of age-related accumulation of Syk ki MZ B cells, we set out to test the idea of B cell autoreactivity caused by aberrant BCR-mediated selection through the hypoactive Sykfamily member Zap-70. We found that Syk ki B cells indeed turned out to specifically react to soluble self-antigens exemplified by high anti-insulin titres. The absence of antinuclear autoantibodies could be explained by various reasons: Either, negative central selection towards particulate self-antigens is still intact, inhibitory FcgRIIB coligation through ICs limits the expansion of high-affinity IgGpositive plasma cells or the Syk ki germinal centre response is to some extent compromised in its ability to generate highaffinity antibodies. The later seems likely because it critically relies on the increase in BCR affinity and related signalling strength to compensate for decreasing antigenic availability. The autoreactive ICs deposited in Syk ki kidneys staining brightly for IgG together with the fasting glucose intolerance of Syk ki mice made us wonder why Syk ki mice failed to develop more severe signs of autoimmune disease. Apart from the fact that, e.g., type 1 diabetes is a multifactorial disease requiring a combination of environmental factors and genetic susceptibilities (Redondo et al, 2001) , the blunted reactivity of stimulating FcgRs in our mouse model system might explain the lack of progression to overt systemic autoimmune disease.
The basis for the very limited ability of Zap-70 to function downstream of B cell antigen receptors and stimulatory ITAM-coupled Fc receptors might be the differences in the way these receptors respond to discrete activation thresholds. FcR-mediated cellular activation acts through immune milieu (cytokine)-dependent co-expression of stimulatory and inhibitory receptors with common ligand binding properties (Nimmerjahn and Ravetch, 2006) . FcRs provide immediate and robust signalling after reaching a critical ligand threshold making rather binary on/off signalling choices. In contrast, BCRs gradually respond to a broad spectrum of antigenic affinities reportedly allowing a certain degree of autoreactivity to avoid B cell repertoire leakiness. Therefore, we hypothesize that attenuated BCR-mediated signal transduction through hypoactive Syk, which may potentially be caused by mutation or loss of protein expression due to epigenetic alterations, allows for the positive selection of auto-/poly-reactive B cell clones and their survival through perpetuate receipt of autoantigenic stimulation. This might be an as yet unidentified risk factor contributing to autoimmune disease.
Materials and methods
Generation of Syk
Zap-70/Zap-70 knock-in mice The Syk ki targeting construct was created by fusing a polyA-tailed human Zap-70 cDNA (NM_001079) in frame with the (first coding) exon 2 ATG of a PAC clone (MRC geneservice UK, RPCI21-501)-derived genomic Syk sequence. Assembly of targeting construct was performed by modified Red/ET recombination, and a frt-flanked Pgk neomycin cassette was used for ES cell selection (Bohmer et al, 2010) . DNA was transfected into R1 (129/Sv Â 129/SvJ) ES cells and resulting colonies were analysed by Southern blotting (EcoRV digest; wt: 10.2 kb; ki: 9.5 kb). Neomycin cassette removal (D) was accomplished by crossing with transgenic Pgk-FLPe mice and verified by PCR. Injection of ES cells into C57BL/6 blastocysts resulted in chimeric mice that were backcrossed with the C57BL/ 6 background to establish the Syk ki line. All animal experiments were approved by the Animal Experimentation Committee of the county of Mü nster and the Federal Ministry of Nature, Environment and Consumer Protection, North Rhine Westphalia.
Antibodies, flow cytometry and B lymphocyte cell cycle analysis
The following antibodies were used in the study: anti-mouse CD3 (145-2C11), CD4 (L3T4), CD8 (53-6.7), CD16/32 (2.4G2), CD19 (1D3), CD21/35 (7G6), CD23 (B3B4), CD25 (3C7), CD43 (S7), CD62L (MEL-14), CD69 (H1.2F3), CD79b (HM79b), CD179/l5 (LM34), B220 (RA3-6B2), BP1, Gr1 (RB6-8C5) and IgM (R6-60.2), all from BD; CD24 (M1/69), CD44 (IM7) and FoxP3 (FJK-16s), all from eBioscience; IgM F(ab 0 ) 2 (Jackson), IgD (11-26c), IgG1, IgG2a and IgG2b, all from Southern Biotech; Syk (N-19), HA (F-7), CD79b (HM-79-12, AT107-2) and C3 (11H9), all from Santa Cruz; pY (4G10, Millipore), Zap-70 (99F2), Erk1/2 and pErk1/2, all from Cell Signaling Technology; HA (ab9134, Abcam); a-tubulin (B-5-1-2, Sigma); GPIb (Xia.G5), GPV (Gon.C2), GPIX (Xia.B4), GPVI (JAQ1), aIIbb3 (JON/A), b3 (Luc.H11), b1 (BD), a2 (Sam.G4), a5 (Tap.A12) and CD9 (Nyn.H3), all from Emfret. The anti-CLEC-2 antibody has been described before (May et al, 2009) . For flow cytometric analysis, preparations of spleen, thymus and flushes of bone marrow (femur and tibia) were blocked in PBS/3% FCS with anti-CD16/32 prior to staining with the indicated antibodies. Cell cycle analysis of B cells was performed by incubating cells for 1 h at 371C with Hoechst 33342 (5 mg/ml) prior to staining with additional markers. Samples were acquired on a BD FACSAria II equipped with three lasers (blue: 488-nm solid state; red: 633-nm HeNe; violet: 405-nm solid state) and data were analysed using FlowJo software (v9.3.2., Treestar).
B cell stimulation, immunoprecipitation and western blotting Sorted B220
þ CD19 þ splenic B cells (purityX98%) or bone marrow cells were stimulated with anti-CD79b or anti-IgM F(ab 0 ) 2 (10 mg/ml each) for the indicated time points and for measurement of total Erk1/2 and pErk1/2 levels immediately lysed in reducing loading buffer (125 mM Tris-HCl (pH 6.8), 2% SDS, 10% glycerol, 1.5% dithiotreitol, 0.001% bromphenol blue) prior to boiling for 5 min at 951C. For immunoprecipitation of HA-Syk, HA-Syk (K402R), HA-Zap-70 and Igbeta, stimulated samples were immediately lysed in RIPA buffer (1% Triton X-100, 150 mM NaCl, 10 mM Tris (pH 7.5), 400 mM EDTA, 0.1% sodium dodecyl sulphate, 0.5% deoxycholate, 10 mM Na 4 P 2 O 7 , 400 mM Na 3 VO 4 , 10 mM NaF, supplemented with protease inhibitor tablets (Roche)), precleared with Pansorbin (Merck), incubated with anti-HA or anti-CD79b antibodies for 1 h at 41C, precipitated with protein G sepharose, washed and boiled in reducing loading buffer. Equivalents of 2 Â10 5 cells/ lane were separated by PAGE, blotted onto nitrocellulose, incubated with the indicated primary and secondary-HRP antibodies and developed with ECL substrate (Thermo).
Ca
2 þ flux measurement Splenic cells were resuspended to a final concentration of 2 Â10 6 /ml and loaded with the fluorescent Ca 2 þ indicator Fluo-4 AM (4 mM) for 30 min in the dark, RT, in HBSS (pH 7.4), 20 mM Hepes, 1.5 mM CaCl 2 , 1 mM MgCl 2 , 1% FCS, 1.5 mM probenecid and 0.05% Pluronic F-127; after washing and 30 min of de-esterification at RT, samples were preheated at 371C for 15 min and stained with anti-B220-APC for the last 5 min of the preheating step; subsequently, cells were washed with prewarmed buffer and after 30 s baseline acquisition stimulated with anti-IgM antibody (2 or 10 mg/ml). For B cell SOCE response measurement, intracellular Ca 2 þ stores were depleted by stimulating cells with anti-IgM (10 mg/ml) in Ca2 þ -free medium ( þ EGTA) for 5 min and subsequently stimulated with 1.5 mM CaCl 2 for additional 5 min; positive controls were measured by the addition of 1 mM ionomycin (Sigma) after baseline acquisition.
Macrophage generation and PMN preparation
Macrophages were generated by seeding 10 6 /ml bone marrow cells in IMDM, 10% FCS, 10% L929 culture supernatant (rmM-CSF), 1% X63/0 culture supernatant (rmIL-3), 50 mM b-ME; after 2 days, nonadherent cells were transferred to new dishes and cultured in IMDM, 10% FCS, 10% L929 culture supernatant, 50 mM b-ME for additional 7 days until 495% of the culture stained positive for F4/80 and CD11b. For the preparation of polymorphonuclear neutrophils, flushes (HBSS, 25 mM Hepes, 10% FCS) of bone marrow were pelleted, resuspended in HBSS, 25 mM Hepes and layered on Histopaque 1077/1119 density gradients for 30 min; after PMN layer isolation, cells were washed twice with HBSS/25 mM Hepes, counted and subjected to phagocytosis assays.
Phagocytosis assays
For the phagocytosis of IgG-opsonized SRBCs (IgG-SRBCs), 10 8 SRBCs (ACILA) were incubated in 1 ml HBSS (pH 7.4), 20 mM Hepes, 1.5 mM CaCl 2 , 1 mM MgCl 2 , 10 mM EDTA with an antihemolysin antibody (1:500, Sigma) for 1 h at 371C, spun down, resuspended in ice-cold HBSS buffer and settled onto plated macrophages at a ratio of B5:1. After 10 min of sedimentation on ice, unbound SRBCs were removed by washing five times with ice-cold PBS, and control samples were immediately fixed with 4% PFA and analysed for homogenous SRBC binding; to initiate phagocytosis, ice-cold PBS was replaced by prewarmed macrophage medium and incubated at 371C for the indicated time points. To remove noninternalized SRBCs, macrophage medium was replaced by red cell lysis buffer (BD Pharmlyse) for 4 min at RT. Finally, SRBC lysis was stopped by the addition of macrophage medium, dishes were washed once with PBS and phase-contrast images were immediately taken on an inverted Nikon microscope (Eclipse TE2000-U) at Â 10 magnification (NA ¼ 0.30). Macrophage internalization of E. coli pHrodo particles (Invitrogen) was assessed by quantifying pHrodo signal intensity (z-stack (8/cell) maximum intensity projection) in relation to cell size (F-actin þ area) of 20 cells per indicated time point with ImageJ; image acquisition was done on a Zeiss LSM-780 laser confocal scanning microscope at Â 63 (NA ¼ 1.40). E. coli pHrodo particle uptake by PMNs was analysed via flow cytometry and is presented as mean fluorescence intensity (MFI) of PE signal at the indicated time points. To analyse BCR uptake kinetics, total splenic cells were stained with anti-IgM-Biotin (Jackson, 10 mg/ml) prior to shifting cells to 371C for the indicated time points; internalization was terminated by adding an excess of ice-cold PBS/3% FCS, followed by staining with Streptavidin-FITC (Jackson, 1:500) and anti-B220-APC (3 mg/ml) on ice. Cells were immediately analysed by flow cytometry, and FITC MFIs of B220 þ cells are displayed as % internalized receptor [( À MFI t / MFI t0 Â100) þ 100] at the indicated time points.
Statistical analysis
Data are presented as mean±s.e.m. We analysed data using Student's t-test and Mann-Whitney rank-sum test as indicated in the figure legends (Sigma Plot 11.0).
Supplementary data
Supplementary data are available at The EMBO Journal Online (http://www.embojournal.org).
